Acquire News - Glycomark News - Glycomark

News

LabFinder.com Increases Diabetes Awareness with Addition of the GlycoMark® Test


Posted on November 18, 2018 by


New York, NY (November 19, 2018)– LabFinder.com, a convenient online platform for patients to schedule their laboratory and radiology tests and access test results, has announced the addition of the GlycoMark® test to its growing subscriber network. The GlycoMark test is an FDA-cleared blood test for detecting recent hyperglycemia and hyperglycemic excursions in patients with…
Read More

GlycoMark®, Inc. Announces Agreement with PrismHealthDx, Inc. to Expand Diabetes Test Panel with the GlycoMark Test


Posted on November 7, 2018 by


New York, NY (November 7, 2018)— GlycoMark, Inc. and PrismHealthDx, Inc. (PHDx) have announced an agreement to offer the GlycoMark® test to clinicians managing patients with diabetes.  The GlycoMark test is the only FDA-cleared blood test for patients with diabetes that is specific to detecting recent hyperglycemia and hyperglycemic excursions (occurring while fasting, postprandial, or…
Read More

GlycoMark®, Inc. to Launch Live Educational Support via GlycoMark.com for Healthcare Professionals during National Diabetes Month


Posted on November 5, 2018 by


New York, NY (November 5, 2018)—GlycoMark, Inc., the exclusive provider of the GlycoMark® test, is launching live educational support for healthcare professionals through its website, http://www.glycomark.com/, as part of National Diabetes Month.  The new complimentary educational support will offer a live chat and video option via the website in November from 9 a.m. – 5…
Read More

Visit GlycoMark at the NJ AACE for complementary GlycoMark testing!


Posted on September 28, 2018 by


Join us while exhibits are open on October 6 to have your blood drawn by Accu Reference Medical Lab, a preferred GlycoMark lab partner and proud sponsor of conference attendee testing. The GlycoMark test is the only FDA-cleared blood test specific to detecting recent hyperglycemia and hyperglycemic excursions (occurring in the fasting state, postprandial, or both).…
Read More

GlycoMark®, Inc. Announces Partnership with Premier Medical Laboratory Services to Expand Diabetes Test Menu


Posted on September 25, 2018 by


New York, NY.  Sept. 25th, 2018 – GlycoMark®, Inc. has announced a partnership with Premier Medical Laboratory Services (PMLS) to increase the availability of the GlycoMark test, the only FDA-cleared blood test specific to detecting recent hyperglycemia and hyperglycemic excursions in patients with diabetes. With the partnership, PMLS will promote and offer the GlycoMark test…
Read More

Visit GlycoMark at the Cardiometabolic Risk Summit


Posted on September 11, 2018 by


Visit GlycoMark’s booth the Cardiometabolic Risk Summit in San Antonio, TX on September 14-15, 2018, to learn more about the GlycoMark test. This test is the only FDA-cleared blood test specific to detecting recent hyperglycemia and hyperglycemic excursions (occurring in the fasting state, postprandial, or both).  To schedule a meeting with one of our experts,…
Read More

Visit GlycoMark’s Booth at AADE 2018


Posted on July 6, 2018 by


Visit booth #748 at AADE18 organized by the American Association of Diabetes Educators in Baltimore, MD on August 17-20, 2018, to learn more about the GlycoMark test. This test is the only FDA-cleared blood test specific to detecting recent hyperglycemia and hyperglycemic excursions (occurring in the fasting state, postprandial, or both).  To schedule a meeting…
Read More

Meet with GlycoMark at AACC 2018!


Posted on July 6, 2018 by


Are you attending the American Association of Clinical Chemistry (AACC) 70th Annual Scientific Meeting & Clinical Lab Expo in August? While in Chicago, meet with GlycoMark’s management team to learn more about the GlycoMark test – the only FDA-cleared blood test specific to detecting recent hyperglycemia and hyperglycemic excursions (occurring in the fasting state, postprandial,…
Read More

GlycoMark to Host Complimentary Educational Program for Healthcare Professionals in Support of National Diabetes Month


Posted on November 2, 2017 by


New York, NY (November 2, 2017)—GlycoMark, Inc., the exclusive provider of the GlycoMark® Test, is sponsoring an educational webinar on hyperglycemia and the GlycoMark Test as part of Diabetes Awareness Month. The complimentary educational program is available to all healthcare professionals managing the more than 30 million Americans with diabetes. Sessions will be held November…
Read More

GlycoMark®, Inc. Partners with Sheil Medical Laboratory to Expand GlycoMark Test in the Northeast


Posted on April 11, 2017 by


Agreement Facilitates Greater Accessibility for Patients and Clinicians to Important Diabetes Test New York, NY (April 11, 2017) – GlycoMark, Inc. announced today a partnership with Shiel Medical Laboratory to expanded distribution of the GlycoMark test throughout the Northeast U.S. GlycoMark is the only clinically available blood test that specifically indicates recent hyperglycemia in patients…
Read More